Scienjoy Holding Corp financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Scienjoy Holding Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		187	262	283	206	187	178
Cost of revenue		147	214	242	179	153	145
Gross profit		40.2	47.8	41.1	27.1	33.6	32.5
Research and development		4.87	11	9.79	10.6	12.4	11.9
Selling and marketing		1.55	0.75	0.31	0.19	0.97	0.91
General and administrative		5.19	10.2	8.85	10.6	10.5	12.7
Operating income	-0.94				3.21	5.58	-11.3
Interest income					0.39	0.44	0.25
Other non-operating income					1.05	0.22	1.25
Pre-tax income		28.1	27.6	30.9	-3.73	5.38	-96.6
Income tax		1.14	0.88	2.62	1.19	1.73	-11.5
Income from continuing operations		29.8	26	21.7
Net income to minority interests				0.27	-0.59	-1.78	-1.13
Net income	0.15	27	26.7	28.3	-4.34	5.44	-84
EBITDA					3.39	5.74	-11.1
EPS, basic	-0.35	1.16	0.87	0.71	-0.11	0.13	-2.01
EPS, diluted	-0.35	1.01	0.87	0.71	-0.11	0.13	-2.01
Shares, basic (weighted)	19.4	23.3	30.8	39.3	40.6	41.4	41.8
Shares, diluted (weighted)	20	26.8	30.8	39.3	40.6	41.6	41.8

Balance sheet

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	21.1	34.4	37.8	25.4	28.9	34.6	44
Short-term investments			6.09	5.88	4.44	5.16	1.22
Receivables	1.57	35	32.4	45.9	36.8	31	6.19
Other current assets	0	2.11	25.9	16.7	11.1	10.2	10
Total current assets	0.01	71.5	102	94.1	81.3	74.6	54.8
Property, plant and equipment		0.21	0.26	0.4	0.31	0.27	0.32
Lease right-of-use assets				2.79	1.71	0.66	2.1
Goodwill		14.1	14.4	25.1	25.7	25
Intangible assets		36.7	37	60.8	58.1	55.5
Long-term investments		0.77	16	34	34.9	36.8	38.8
Total assets	58.6	124	171	218	204	193	102
Accounts payable		10.3	13.5	16.9	10.3	4.93	2.38
Accrued liabilities		2.78	3.85	1.8	2.08
Deferred revenue		7.6	10.3	13.5	13.7	11	7.22
Total current liabilities	0.22	42.5	34.7	38.5	33	22	15.2
Lease liabilities				1.85	0.68	0.1	1.49
Total liabilities	2.7	54	43.9	49.2	42.1	30.1	16.7
Total debt			1.26	2.18	2.28
Retained earnings	0.09	49.4	75.2	96.4	88.6	90.8	13.2
Treasury stock				-2.39	-2.71	-2.73	-2.85
Other comprehensive income		2.27	2.69	2.62	2.53	2.32	1.84
Shareholders' equity	5	70.4	127	168	162	164	88
Minority interests				0.27	-0.12	-1.89	-3.14
Total equity	5	70.4	127	169	162	162	84.9
Total liabilities and equity	58.6	124	171	218	204	193	102
Shares outstanding	19.4	27

Cash flow statement

	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	0.15	27	26.7	28.3	-4.93	3.66	-85.1
Depreciation and amortization		0.09	0.12	0.17	0.17	0.15	0.17
Stock-based compensation			5	1.73	1.92	1.45	1.07
Deferred income tax		0.3	0.05	-0.2	-0.63	-0.21	-12.6
Change in receivables		-10.8	3.69	-16.2	7.63	4.7	7.93
Change in payables	0.22	4.35	2.94	3.7	-6.07	-5.09	-2.77
Cash from operations	-0.72	23.8	18.3	8.35	14.5	9.42	10.1
Capital expenditures		-0.17	-0.22	-0.31	-0.07	-0.14	-0.12
Acquisitions			-43.8				-0.18
Cash from investing	-57.5	-6.27	-18.1	-16.4	-9.46	-2.75	-0.87
Debt repaid		-8.8			-1.41
Share buybacks				-2.39	-0.39	-0.1
Cash from financing	58.2	-3.58	2.4	-1.67	-0.74	-0.02	-0.01
Exchange rate effect		-0.57	-0.04	0.22	-0.02	-0.2	-1.32
Net change in cash	-0.04	13.4	2.54	-9.52	4.25	6.45	7.88
Free cash flow		23.7	18	8.03	14.4	9.28	9.96
Income taxes paid		1.06	1.49			-2.17	-1.18

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $0.69 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	18.3%	Gross profit / revenue.
Operating margin	-6.4%	Operating income / revenue.
EBITDA margin	-6.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-54.4%	Pre-tax income / revenue.
Net margin	-47.3%	Net income / revenue.
FCF margin	5.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.7%	Cash from operations / revenue.
Return on equity (ROE)	-66.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-57.1%	Net income / average total assets.
Return on invested capital (ROIC)	-10.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	6.7%	Research and development expense / revenue.
Stock-based pay / revenue	0.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.1%	Capital expenditures / revenue.
D&A / revenue	0.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-4.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-14.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-1.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-7.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-4.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-302.1%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-293.7%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-1,644.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-1,646.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	7.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-15.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	7.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	7.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-15.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-46.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-19.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-47.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-22.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	9.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.60x	Current assets / current liabilities.
Quick ratio	3.37x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	2.97x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	16.5%	Total liabilities / total assets.
Working capital	$39.6M	Current assets - current liabilities.
Tangible book value	$88.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.21x	Revenue / average total assets.
Fixed asset turnover	600x	Revenue / average property, plant and equipment.
Receivables turnover	9.56x	Revenue / average receivables.
Days sales outstanding	38 days	365 x average receivables / revenue.
Days payables	9 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	1.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$2.01	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	-$2.01	Net income per basic share, as reported (split-adjusted).
Revenue per share	$4.25	Revenue / diluted weighted shares.
FCF per share	$0.24	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.24	Cash from operations / diluted weighted shares.
Book value per share	$2.11	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.11	Tangible book value / shares outstanding.
Cash per share	$1.08	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$29.3M	Share price x shares outstanding.
Enterprise value	-$15.9M	Market cap + total debt - cash - short-term investments.
P/S	0.17x	Market cap / revenue.
P/B	0.33x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.33x	Market cap / tangible book value, when positive.
P/FCF	2.94x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	2.91x	Market cap / cash from operations, when positive.
FCF yield	34.0%	Free cash flow / market cap.
Earnings yield	-286.5%	Net income / market cap (the inverse of P/E).

What was Scienjoy Holding Corp's revenue in fiscal 2025?

Scienjoy Holding Corp reported revenue of $177.5M for fiscal 2025, 4.9% lower than the year before.

Was Scienjoy Holding Corp profitable in fiscal 2025?

No. It reported a net loss of $84.0M.

How much free cash flow did Scienjoy Holding Corp generate in fiscal 2025?

Cash from operations of $10.1M minus capital expenditures of $120.0K left free cash flow of $10.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Scienjoy Holding Corp